Women's experiences of living with obesity during pregnancy, birthing, and postpartum: a qualitative systematic
Erna Snelgrove-Clarke1,2, Danielle Macdonald1,2, Melissa Helwig3,4
1School of Nursing, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.
Objective:
The objective of this review is to explore and understand women's experiences of living with obesity during the perinatal period to support evidence-informed approaches to care.
Introduction:
The rising incidence of maternal obesity is a serious global health problem. Qualitative studies exploring the viewpoints of pregnant women living with obesity have shown that some women report negative experiences associated with pregnancy, with some instances of current care management practices being perceived as confronting, judgmental, and generally unhelpful. Synthesizing qualitative findings about the experiences of pregnant and postpartum women who live with obesity can provide important insights into the general needs of this population and current gaps in health care practice.
Inclusion Criteria:
All settings in which women who live with obesity during their pregnancies and receive health care for pregnancy, birthing, and postpartum care will be considered. Studies published from 1995 onward will be included. The review will consider all studies that present qualitative data including, but not limited to, designs such as phenomenology, grounded theory, ethnography, action research, and feminist research.
Methods:
The following databases will be searched for this review: CINAHL (EBSCO), Embase (Elsevier), PsycINFO (EBSCO), MEDLINE (Ovid), and Sociological Abstracts (ProQuest). ProQuest Dissertations and Theses will be searched for unpublished studies. Each study will be assessed by two independent reviewers. Any disagreements will be resolved through discussion. Data extraction will be conducted by two independent reviewers. The JBI resources for meta-aggregation will be used to create categories and synthesized findings.
Systematic Review Registration Number:
PROSPERO CRD42020214762.
Related Concept Videos
Obesity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Diabetes Mellitus: Type 2 and Gestational


